• Journal of KIISE:Computer Systems and Theory
• /
• v.33 no.8
• /
• pp.514-523
• /
• 2006

In this paper we propose an extended interleaving technique to improve a detailed placement. The existing row-based interleaving technique allows cells to move only within a row and it can be applied when there is no space between cells. The proposed extended-interleaving technique releases such constraints so that cells can move along with a vertical line parallel to a y-axis and space between cells is properly handled. Converged detailed-placements by a mature CAD tool have been improved by the proposed interleaving technique by 9.5% on average in half-perimeter wire length.

• Culinary science and hospitality research
• /
• v.14 no.1
• /
• pp.161-169
• /
• 2008

This study was performed to find out the quality characteristics of rice noodles by addition of red ginseng(0, 2, 6, 10%). The quality characteristics of the sample were estimated in terms of general composition, growth of microorganism and sensory evaluation. The results from this study were as follows. The protein, lipid and ash contents did not show significant difference in any of the groups. In dry rice noodles, moisture content significantly decreased in red ginseng groups but, in half-cooked rice noodles, moisture content significantly increased in 6 % and 10% red ginseng added groups(p<0.05). The microbial count showed less growth in red ginseng added groups after 3 months(p<0.05). According to sensory evaluation, surface color proved very good in the 10% red ginseng added group among the training panel while very good in the 2% red ginseng added group among consumers. Flavor was good in red ginseng added groups(p<0.05). Taste was very good in the 3% red ginseng added group. Appearance and overall quality were highest in the 2% and 6% red ginseng added groups(p<0.05). Therefore, rice noodles containing 2% or 6% red ginseng were most preferable and safe during 5 months and 6 days in dry and half-cooked noodles respectively.

• Journal of Power Electronics
• /
• v.13 no.1
• /
• pp.20-30
• /
• 2013

This paper presents a soft switching DC/DC converter for high voltage application. The interleaved pulse-width modulation (PWM) scheme is used to reduce the ripple current at the output capacitor and the size of output inductors. Two converter cells are connected in series at the high voltage side to reduce the voltage stresses of the active switches. Thus, the voltage stress of each switch is clamped at one half of the input voltage. On the other hand, the output sides of two converter cells are connected in parallel to achieve the load current sharing and reduce the current stress of output inductors. In each converter cell, a half-bridge converter with the asymmetrical PWM scheme is adopted to control power switches and to regulate the output voltage at a desired voltage level. Based on the resonant behavior by the output capacitance of power switches and the transformer leakage inductance, active switches can be turned on at zero voltage switching (ZVS) during the transition interval. Thus, the switching losses of power MOSFETs are reduced. The current doubler rectifier is used at the secondary side to partially cancel ripple current. Therefore, the root-mean-square (rms) current at output capacitor is reduced. The proposed converter can be applied for high input voltage applications such as a three-phase 380V utility system. Finally, experiments based on a laboratory prototype with 960W (24V/40A) rated power are provided to demonstrate the performance of proposed converter.

• Annals of Pediatric Endocrinology and Metabolism
• /
• v.22 no.1
• /
• pp.15-26
• /
• 2017

The prevalence of type 2 diabetes (T2D) is increasing worldwide. Patients with T2D suffer from various diabetes-related complications. Since there are many patients with T2D that cannot be controlled by previously developed drugs, it has been necessary to develop new drugs, one of which is a glucagon-like peptide-1 (GLP-1) based therapy. GLP-1 has been shown to ameliorate diabetes-related conditions by augmenting pancreatic ${\beta}-cell$ insulin secretion and having the low risk of causing hypoglycemia. Because of a very short half-life of GLP-1, many researches have been focused on the development of GLP-1 receptor (GLP-1R) agonists with long half-lives such as exenatide and dulaglutide. Now GLP-1R agonists have a variety of dosing-cycle forms to meet the needs of various patients. In this article, we review the physiological features of GLP-1, the effects of GLP-1 on T2D, the features of several GLP-1R agonists, and the therapeutic effect on T2D.

• Journal of the Korea Institute of Information Security & Cryptology
• /
• v.12 no.2
• /
• pp.53-64
• /
• 2002

This paper describes a design of cryptographic processor that implements the AES (Advanced Encryption Standard) block cipher algorithm, "Rijndael". An iterative looping architecture using a single round block is adopted to minimize the hardware required. To achieve high throughput rate, a sub-pipeline stage is added by dividing the round function into two blocks, resulting that the second half of current round function and the first half of next round function are being simultaneously operated. The round block is implemented using 32-bit data path, so each sub-pipeline stage is executed for four clock cycles. The S-box, which is the dominant element of the round block in terms of required hardware resources, is designed using arithmetic circuit computing multiplicative inverse in GF($2^8$) rather than look-up table method, so that encryption and decryption can share the S-boxes. The round keys are generated by on-the-fly key scheduler. The crypto-processor designed in Verilog-HDL and synthesized using 0.25-$\mu\textrm{m}$ CMOS cell library consists of about 23,000 gates. Simulation results show that the critical path delay is about 8-ns and it can operate up to 120-MHz clock Sequency at 2.5-V supply. The designed core was verified using Xilinx FPGA board and test system.

• Journal of Marine Bioscience and Biotechnology
• /
• v.13 no.1
• /
• pp.28-47
• /
• 2021

Pectin is a natural polysaccharide and biopolymer that serves as a structural component of plant tissues' primary cell walls. Pectin is primarily composed of D-galacturonic acid linked by α-1, 4-glycosidic linkage and is further classified by the ratio of esterified galacturonic acid groups known as degree of esterification (DE). Pectin that contains more than half of its carboxylate units as methyl esters is known as a high methyl (HM) ester. Conversely, pectin that has less than half of its carboxylate units as methyl esters is known as a low methyl (LM) ester. Pectin has various bioactive properties, including anticancer, anti-inflammatory, antioxidant, antidiabetic, anticholesterol, antitumoral, and chemopreventive properties. Moreover, pectin is a useful biopolymer in biomedical applications. Biomedical engineering, which is founded on research aimed to improve the quality of life using new materials and technologies, is typically classified according to the use of hydrogels, nanofiber mats, and nanoparticles. This paper reviews the progress of recent research into pectin-based biomedical applications and the potential future biomedical applications of marine-derived pectin.

• Journal of the Korean Association of Oral and Maxillofacial Surgeons
• /
• v.30 no.6
• /
• pp.474-481
• /
• 2004

Squamous cell carcinoma is the most prevalent oral cancer, which is characterized by its low survival rate, high malignancy, mortality with facial defects, and poor prognosis. Exact cause and pathogenesis of the squamous cell carcinoma is still unknown. Various routes including smoking, radiation, and viral infections predispose its genesis, and recent studies revealed that genetic defects which fail to prevent cancer proliferation play a role. Generally, a cancer develops from the decreased rate of apoptosis which is an active and voluntary cell death, and from the altered cell cycles. Anticancer effect can be obtained by recovering the apoptotic process, and by suppressing the cell cycles. Among the apoptosis related factors, bcl-2, caspase-9, and VDAC (voltage-dependent anion channel)are produced in mitochondria of the cell. Cyclosporin-A is known to induce apoptosis through its activation with VDAC. This study was to reveal the anticancer effect of Cyclosporin A to the oral squamous cell carcinoma. The inverted microscope was used to find alterations in the tissue, and sensitivity test to the anticancer cells was performed with MTT (Tetrazolium-based colorimetric) assay. Following cell line culture of primary and metastastic oral squamous cell carcinoma, electrophoresis was performed with extracted total RNA. Finally, semi-quantitative study was carried out through RT-PCR (Reverse Transcription-Polymerase Chain Reaction). The results of this study are as follows: 1. The inverted microscopic observation revealed a poorly defined cytoplasm at $2000ng{\sim}3000ng/ml$, indistinct nucleus, and apoptosis. 2. The Growth of cancer cells was decreased at 1000ng/ml of cyclosporin-A. No cancer cell growth was observed at over 2000ng/ml concentration of cyclosporin-A, and at one week, growth of cancer cells was ceased. 3. The MTT assays were decreased as cyclosporin-A concentration was increased. This means that the activation of succinyl dehydrogenase in mitochondria was decreased following administration of cyclosporin A. 4. A result of RT-PCR showed that amount of mRNA of VDAC-2 was decreased half times at a cyclosporine-A concentration of 2000ng/ml. In bcl-2, amount of mRNA was significantly decreased 1/5 times at 2000ng/ml. caspase-9, however, showed slight increase compared to the control group. From the results obtained in this study, administration of cyclosporin-A to the cell lines of oral squamous cell carcinoma induced alterations in morphology and growth of the cells as its concentration increased. Since apoptosis related factors such as VDAS-2, bcl-2, and caspase-9 also showed distinct alterations on their mRNAs, further research on cyclosporin A as an anti-cancer agent will be feasible.

• The Journal of the Korea Contents Association
• /
• v.8 no.7
• /
• pp.85-92
• /
• 2008

Meshes are the most appropriate data structures for representing 3D geometries. Surface meshes have been frequently used for representing 3D geometries, which only samples data on the surfaces of the given 3D geometries. Thanks to the improvements of computing powers, it is required to develop more complicated contents which utilize the volumetric information of 3D geometries. In this paper, we introduce a novel volumetric mesh libraries based on the half-face data structure, called OpenVolMesh, and describe its designs and implementations. The OpenVolMesh extends the OpenMesh, which is one of the most famous mesh libraries, by supporting volumetric meshes. The OpenVolMesh provides the generic programming, dynamic allocations of primitive properties, efficient array-based data structures, and source-level compatibility with OpenMesh. We show the usefulness of the OpenVolMesh in the developments of 3D volumetric contents with prototypic implementations such as volumetric mesh smoothing and CW-cell decompositions.

• Journal of the Korean Institute of Telematics and Electronics
• /
• v.25 no.9
• /
• pp.1115-1124
• /
• 1988

A two-dimensional systolic array for fast Fourier transform, which has a regular and recursive VLSI architecture is presented. The array is constructed with identical processing elements (PE) in mesh type, and due to its modularity, it can be expanded to an arbitrary size. A processing element consists of two data routing units, a butterfly arithmetic unit and a simple control unit. The array computes FFT through three procedures` I/O pipelining, data shuffling and butterfly arithmetic. By utilizing parallelism, pipelining and local communication geometry during data movement, the two-dimensional systolic array eliminates global and irregular commutation problems, which have been a limiting factor in VLSI implementation of FFT processor. The systolic array executes a half butterfly arithmetic based on a distributed arithmetic that can carry out multiplication with only adders. Also, the systolic array provides 100% PE activity, i.e., none of the PEs are idle at any time. A chip for half butterfly arithmetic, which consists of two BLC adders and registers, has been fabricated using a 3-um single metal P-well CMOS technology. With the half butterfly arithmetic execution time of about 500 ns which has been obtained b critical path delay simulation, totla FFT execution time for 1024 points is estimated about 16.6 us at clock frequency of 20MHz. A one-PE chip expnsible to anly size of array is being fabricated using a 2-um, double metal, P-well CMOS process. The chip was layouted using standard cell library and macrocell of BLC adder with the aid of auto-routing software. It consists of around 6000 transistors and 68 I/O pads on 3.4x2.8mm\ulcornerarea. A built-i self-testing circuit, BILBO (Built-In Logic Block Observation), was employed at the expense of 3% hardware overhead.

• Tuberculosis and Respiratory Diseases
• /
• v.84 no.2
• /
• pp.134-139
• /
• 2021

Background: Intrapleural urokinase is one of the most widely used fibrinolytic agents in the treatment of complicated parapneumonic effusion (CPPE). However, little research has been performed on the optimal urokinase dosage. The aim of this study was to evaluate the treatment efficacy of half dose urokinase compared with conventional dose urokinase. Methods: We retrospectively enrolled 92 patients with CPPE or empyema who underwent intrapleural urokinase treatment at two tertiary hospitals. Patients received antibiotics, chest tube drainage, and other treatments as part of routine care. The primary outcome was the treatment success rate in the half dose urokinase group (50,000 IU daily for maximal 6 days) and the conventional dose urokinase group (100,000 IU daily). Treatment success was defined as clinical and radiological improvements without surgical treatment or re-admission within one month. Results: Forty-four patients received half dose urokinase, whereas 48 patients were treated with conventional dose urokinase. Both groups were relatively well matched at baseline, excluding higher serum white blood cell count and higher empyema prevalence in the half dose urokinase group. The treatment success rate was not different between the two groups (p=0.048). There were no differences in the rate of in-hospital death and surgical treatment, hospitalization duration, and indwelling catheter duration. In the multivariate analysis, urokinase dose was not a predictor of treatment success. Conclusion: Half dose intrapleural urokinase is equally effective conventional dose urokinase in treating patients with CPPE or empyema.